DexCom Inc. (DXCM)
| Sector: | Health Care |
| |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 373 |
| % of all portfolios: | 0.013% |
| Hold Price * : | $124.09 |
| History |
Portfolio Manager |
Activity ▼ |
Share change |
% change to portfolio |
| Q4 2023 |
| ≡ |
Chase Coleman - Tiger Global Management |
Buy |
1,152,806 |
1.02 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 58.54% |
6,885 |
0.01 |
| Q3 2023 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
11,761 |
0.03 |
| Q4 2021 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Sell 100.00% |
5,764,908 |
2.66 |
| Q3 2021 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Reduce 22.86% |
1,708,240 |
0.79 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
844 |
0.00 |
| Q2 2021 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Reduce 21.27% |
2,019,444 |
0.69 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 92.82% |
10,912 |
0.00 |
| Q1 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 1021.76% |
10,708 |
0.01 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Add 4.64% |
421,356 |
0.14 |
| Q4 2020 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Add 389.72% |
7,218,888 |
2.43 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 27.62% |
400 |
0.00 |
| Q3 2020 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Add 36.38% |
494,164 |
0.22 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
1,448 |
0.00 |
| Q2 2020 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Buy |
1,358,184 |
0.71 |
| Q1 2020 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Sell 100.00% |
4,235,580 |
1.24 |
| Q4 2019 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Buy |
4,235,580 |
1.24 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.